MA25.04 Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC

C Aggarwal, J Thompson + Show 12 more

Open Access

https://doi.org/10.1016/j.jtho.2019.08.712

Copy DOI

Journal: Journal of Thoracic Oncology	Publication Date: Oct 1, 2019
Citations: 5	License type: publisher-specific-oa

Abstract

MA25.04 Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author